MRNA260116C00020000 Option on Moderna

MRNA Stock  USD 25.11  0.62  2.41%   
Moderna's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 1.73 with a put-to-call open interest ratio of 0.96 over 82 outstanding agreements suggesting . The total put volume is at 3.8 K, with calls trading at the volume of K. This yields a 0.77 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows Moderna's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Moderna's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Moderna's option, there is no secondary market available for investors to trade.

Moderna Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Moderna close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Moderna's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Moderna

Analyzing Moderna's in-the-money options over time can help investors to take a profitable long position in Moderna regardless of its overall volatility. This is especially true when Moderna's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Moderna's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Moderna's stock while costing only a fraction of its price.
Moderna's stock options are financial instruments that give investors the right to buy or sell shares of Moderna common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Moderna stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Moderna's stock price goes up or down, the stock options follow.
At present, Moderna's Sale Purchase Of Stock is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 450.4 M, whereas Total Stockholder Equity is forecasted to decline to about 6.5 B.

Moderna In The Money Call Balance

When Moderna's strike price is surpassing the current stock price, the option contract against Moderna stock is said to be in the money. When it comes to buying Moderna's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Moderna are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Moderna Current Options Market Mood

Moderna's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Moderna Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Moderna's options investors are not very successful. Moderna's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Moderna contract

Base on the Rule 16, the options market is currently suggesting that Moderna will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-06-20 option contract. With Moderna trading at USD 25.11, that is roughly USD 0.0272. If you think that the market is fully incorporating Moderna's daily price movement you should consider buying Moderna options at the current volatility level of 1.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Moderna options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Moderna calls. Remember, the seller must deliver Moderna stock to the call owner when a call is exercised.

Moderna Option Chain

When Moderna's strike price is surpassing the current stock price, the option contract against Moderna stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Moderna's option chain is a display of a range of information that helps investors for ways to trade options on Moderna. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Moderna. It also shows strike prices and maturity days for a Moderna against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
MRNA250620C00230000598230.00.0 - 0.30.01Out
Call
MRNA250620C00220000112220.00.0 - 0.510.02Out
Call
MRNA250620C00210000454210.00.0 - 0.370.02Out
Call
MRNA250620C00200000444200.00.0 - 0.090.02Out
Call
MRNA250620C00195000139195.00.0 - 0.460.1Out
Call
MRNA250620C0019000071190.00.01 - 0.20.15Out
Call
MRNA250620C00185000124185.00.0 - 2.150.09Out
Call
MRNA250620C00180000425180.00.02 - 0.370.05Out
Call
MRNA250620C00175000386175.00.0 - 2.160.3Out
Call
MRNA250620C00170000255170.00.01 - 0.890.07Out
Call
MRNA250620C00165000137165.00.0 - 0.530.22Out
Call
MRNA250620C00160000368160.00.0 - 0.10.01Out
Call
MRNA250620C00155000119155.00.0 - 0.550.1Out
Call
MRNA250620C001500001075150.00.0 - 0.160.08Out
Call
MRNA250620C00145000177145.00.01 - 1.510.26Out
Call
MRNA250620C00140000191140.00.0 - 1.310.15Out
Call
MRNA250620C00135000656135.00.0 - 0.190.09Out
Call
MRNA250620C00130000283130.00.0 - 0.150.08Out
Call
MRNA250620C00125000338125.00.0 - 0.250.15Out
Call
MRNA250620C00120000242120.00.0 - 0.180.1Out
Call
MRNA250620C001150001326115.00.02 - 0.350.13Out
Call
MRNA250620C001100001931110.00.02 - 0.290.08Out
Call
MRNA250620C001050001428105.00.01 - 0.340.19Out
Call
MRNA250620C001000002960100.00.03 - 0.10.08Out
Call
MRNA250620C0009500094395.00.0 - 0.70.15Out
Call
MRNA250620C00090000111290.00.01 - 0.70.1Out
Call
MRNA250620C0008500089185.00.04 - 0.520.53Out
Call
MRNA250620C00080000170380.00.02 - 1.240.14Out
Call
MRNA250620C0007500099775.00.05 - 0.330.12Out
Call
MRNA250620C00070000439670.00.12 - 0.50.19Out
Call
MRNA250620C00065000277265.00.07 - 0.390.14Out
Call
MRNA250620C00060000288860.00.17 - 0.510.2Out
Call
MRNA250620C00055000218555.00.2 - 0.260.25Out
Call
MRNA250620C00050000469550.00.3 - 0.330.33Out
Call
MRNA250620C00045000430545.00.4 - 0.510.42Out
Call
MRNA250620C00040000506840.00.68 - 1.20.72Out
Call
MRNA250620C00035000284635.01.2 - 1.311.25Out
Call
MRNA250620C00030000183730.02.0 - 2.342.33Out
Call
MRNA250620C0002500041525.04.0 - 5.154.3Out
Call
MRNA250620C000225001722.54.4 - 7.05.55In
Call
MRNA250620C000200009520.06.1 - 7.26.7In
Call
MRNA250620C000175005017.57.9 - 10.98.0In
Call
MRNA250620C000150008115.010.65 - 11.311.02In
 Put
MRNA250620P0001500037915.00.4 - 0.590.53Out
 Put
MRNA250620P00017500172917.50.86 - 1.070.9Out
 Put
MRNA250620P00020000426620.01.55 - 1.771.65Out
 Put
MRNA250620P00022500377022.52.32 - 2.782.55Out
 Put
MRNA250620P00025000550625.02.93 - 3.853.65Out
 Put
MRNA250620P00030000685430.06.75 - 7.956.71In
 Put
MRNA250620P00035000737035.010.0 - 11.111.09In
 Put
MRNA250620P00040000744240.014.9 - 15.415.22In
 Put
MRNA250620P00045000252945.019.7 - 20.619.88In
 Put
MRNA250620P00050000338850.024.35 - 25.725.7In
 Put
MRNA250620P00055000318955.029.75 - 30.2530.25In
 Put
MRNA250620P00060000152760.033.6 - 36.034.81In
 Put
MRNA250620P00065000103065.037.5 - 42.038.05In
 Put
MRNA250620P000700007870.042.5 - 47.044.1In
 Put
MRNA250620P00075000875.047.65 - 52.046.51In
 Put
MRNA250620P000800001380.053.0 - 57.554.1In
 Put
MRNA250620P000850003085.058.0 - 61.959.4In
 Put
MRNA250620P0009000012890.063.0 - 67.565.05In
 Put
MRNA250620P000950001495.068.0 - 72.570.15In
 Put
MRNA250620P0010000030100.073.6 - 76.7573.6In
 Put
MRNA250620P0010500026105.077.65 - 81.979.63In
 Put
MRNA250620P0011000015110.083.0 - 86.985.15In
 Put
MRNA250620P001150008115.087.65 - 91.980.51In
 Put
MRNA250620P0012000014120.093.0 - 97.593.96In
 Put
MRNA250620P0012500012125.098.05 - 101.85100.25In
 Put
MRNA250620P0013000012130.0103.0 - 106.9103.65In
 Put
MRNA250620P001350003135.0107.65 - 111.9102.59In
 Put
MRNA250620P001400009140.0112.5 - 117.0108.45In
 Put
MRNA250620P001450007145.0117.65 - 121.9113.49In
 Put
MRNA250620P001700000170.0142.65 - 146.970.95In
 Put
MRNA250620P001750000175.0147.5 - 152.041.05In
 Put
MRNA250620P001800000180.0152.75 - 156.744.5In
 Put
MRNA250620P001850000185.0159.05 - 162.599.71In
 Put
MRNA250620P001900000190.0162.5 - 167.0162.5In
 Put
MRNA250620P001950000195.0167.65 - 171.9167.65In
 Put
MRNA250620P002000000200.0172.5 - 177.0165.42In
 Put
MRNA250620P002100000210.0182.65 - 186.969.2In
 Put
MRNA250620P002200000220.0192.65 - 196.9100.0In
 Put
MRNA250620P002300000230.0202.5 - 206.9106.3In

Moderna Total Stockholder Equity

Total Stockholder Equity

6.48 Billion

At present, Moderna's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Moderna Corporate Management

Shannon KlingerChief SecretaryProfile
Brad MillerChief OfficerProfile
Melanie MBAChief OfficerProfile
James MockChief OfficerProfile
Stephane BancelCEO DirectorProfile
John ReyndersChief OfficerProfile
Ruchi JainPrincipal ScientistProfile
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.85)
Earnings Share
(9.28)
Revenue Per Share
8.427
Quarterly Revenue Growth
(0.66)
Return On Assets
(0.15)
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.